215. Post-authorisation provisions in relation to paediatric-specific provisions.

Where the holder of a UK marketing authorisation1 intends to discontinue supply of the product to which that authorisation relates2, and benefited from a paediatric reward3 or orphan reward4 in relation to the product5, and the period of protection provided by that reward has expired6, the holder must either transfer the UK marketing authorisation to another person who has